Private Equity Portfolio Company
TLC
Taipei
Taiwan
https://www.tlcbio.com/en-global
Taiwan Liposome Company (TLC) is a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of novel nanomedicines that combine its proprietary lipid-assembled liposome drug delivery platform with a...
Private Equity Owner: PAG
Executives
Acquisition Criteria
Investment Date:
Exit Date:
Status:
Add-on Acquisitions:
Industry (NAICS Code):
Testimonials
Become the next customer to share a success story about Private Equity Info's impact.
"Private Equity Info is critical to nearly every aspect of our role as an investment bank. We use it almost every day and the return on investment is clear."
Bob McCormack
"PEI is superior for our sales team. It cuts to the core. It’s the sweet spot in terms of what you’re paying and what you’re getting.”
